Immune system disorders in children can involve an underactive, overactive, or misdirected immune response. Main groups include immunodeficiencies, autoimmune diseases, atopic diseases, and ...

In 2026, the unprecedented pediatric patient crowding of 2022 has become a normal Tuesday,” write Jonathan Kohler and Mary ...

More children are getting diseases such as celiac disease, type 1 diabetes and inflammatory bowel disease (IBD) than before, research shows. IBD is a term for conditions like ulcerative colitis and ...

A review highlights the need for better research on pediatric segmental vitiligo treatments, as current options show mixed results, and at SPD 2025, Hira Ghani, DO, emphasized the importance of ...

Children can benefit from a variety of dermatologic laser procedures, from hair removal to treatment of scars and vascular anomalies. However, the data on the safety and effectiveness of lasers for ...

When our son Peter was diagnosed with an ultra-rare form of muscular dystrophy at the age of 10, the first question we asked was: Is there a treatment? The answer was no. By the time our daughter ...

Childhood cancer is a nightmare for any family. Active research into how pediatric cancers develop and how doctors can effectively treat them has been fruitful: 5-year survival rates for pediatric ...

The Ortolani maneuver can help show hips that are dislocated when the infant is in a resting position. In this test, the trained examiner attempts to reduce an already dislocated hip. The infant’s ...

Early antibiotic exposure was positively associated with asthma, food allergy, and allergic rhinitis HealthDay News — Children receiving multiple antibiotic courses between birth and age 2 years may ...

The prevalence of chronic conditions has risen to unprecedented levels over the past twenty years, with nearly 1-in-3 young people estimated to now be living with pediatric onset conditions that ...

Please provide your email address to receive an email when new articles are posted on . Researchers identified new sites in the placenta where genomic imprinting occurs. This could find previously ...

European regulators have backed earlier use of two orphan therapies for rare pediatric diseases that affect muscle and bone development, lowering treatment age thresholds for both medicines. At its ...